Feedback / Questions
EB103 - Estrella Biopharma
https://www.businesswire.com/news/home/20250605259623/en/Estrella-Immunopharma-Announces-Activation-of-Additional-Site-for-Phase-III-STARLIGHT-1-Trial-in-B-cell-Non-Hodgkins-Lymphoma
Jun 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next